Cargando…

Prognostic Significance of Tumor Regression in Locally Advanced Rectal Cancer after Preoperative Radiochemotherapy

BACKGROUND: The majority of rectal cancers are discovered in locally advanced forms (UICC stage II, III). Treatment consists of preoperative radiochemotherapy, followed by surgery 6–8 weeks later and finally by postoperative chemotherapy. The aim of this study was to find out if tumor regression aff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omejc, Mirko, Potisek, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter Open 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839079/ https://www.ncbi.nlm.nih.gov/pubmed/29520203 http://dx.doi.org/10.1515/raon-2017-0059

Ejemplares similares

Prognostic Significance of Tumor Regression Grade after Preoperative Chemoradiotherapy for Rectal Cancer
por: Kim, Byung Chun
Publicado: (2011)

Association Between the Cytogenetic Profile of Tumor Cells and Response to Preoperative Radiochemotherapy in Locally Advanced Rectal Cancer
por: González-González, María, et al.
Publicado: (2014)

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
por: Dellas, Kathrin, et al.
Publicado: (2013)

Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer
por: Rengo, Marco, et al.
Publicado: (2017)

Clinical Significance of Tumor Regression Grade in Rectal Cancer with Preoperative Chemoradiotherapy
por: Park, Young Joo, et al.
Publicado: (2010)

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy
por: Negri, F V, et al.
Publicado: (2008)

The Influence of the Distal Resection Margin Length on Local Recurrence and long- term Survival in Patients with Rectal Cancer after Chemoradiotherapy and Sphincter- Preserving Rectal Resection
por: Grosek, Jan, et al.
Publicado: (2016)

Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
por: Ratosa, Ivica, et al.
Publicado: (2015)

Forecasting Individual Patients’ Best Time for Surgery in Colon-Rectal Cancer by Tumor Regression during and after Neoadjuvant Radiochemotherapy
por: Martorana, Emanuele, et al.
Publicado: (2023)

Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer
por: Zhang, Lu-Ning, et al.
Publicado: (2016)

Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
por: Schuster, Barbara, et al.
Publicado: (2021)

Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas
por: Schem, Baard-Christian, et al.
Publicado: (2022)

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
por: Velenik, Vaneja, et al.
Publicado: (2011)

Evaluation of Efficacy and Tolerance of Radical Radiotherapy and Radiochemotherapy in Treatment of Locally Advanced, Unresectable Rectal Cancer
por: Kraszkiewicz, M., et al.
Publicado: (2022)

Tumor Volume Regression during and after Radiochemotherapy: A Macroscopic Description
por: Castorina, Paolo, et al.
Publicado: (2022)

Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
por: Mallet, Romain, et al.
Publicado: (2020)

Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society
por: Siegel, Robert, et al.
Publicado: (2009)

Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors
por: Ferrigno, Robson, et al.
Publicado: (2006)

Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

Total Neoadjuvant Treatment of Locally Advanced Rectal Cancer with High Risk Factors in Slovenia
por: Tuta, Mojca, et al.
Publicado: (2019)

Prognostic impact of tumor size reduction assessed by magnetic resonance imaging after radiochemotherapy in patients with locally advanced cervical cancer
por: Cordoba, Abel, et al.
Publicado: (2022)

microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer
por: Liu, Xiaowen, et al.
Publicado: (2018)

Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data
por: Wang, Xin, et al.
Publicado: (2018)

Clinical Impact of Tumor Regression Grade after Preoperative Chemoradiation for Locally Advanced Rectal Cancer: Subset Analyses in Lymph Node Negative Patients
por: Min, Byung Soh, et al.
Publicado: (2011)

High-Risk Clinicopathological and Genetic Features and Outcomes in Patients Receiving Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer
por: del Carmen, Sofía, et al.
Publicado: (2021)

Detection of morphologic alterations in rectal carcinoma following preoperative radiochemotherapy based on multiphoton microscopy imaging
por: Li, Lianhuang, et al.
Publicado: (2015)

Influence of Concurrent Capecitabine Based Chemoradiotherapy with Bevacizumab on The Survival Rate, Late Toxicity and Health-related Quality of Life in Locally Advanced Rectal Cancer: a Prospective Phase II CRAB Trial
por: Velenik, Vaneja, et al.
Publicado: (2020)

Associations of tumor regression grade with outcomes in patients with locally advanced rectal cancer treated with preoperative two-week course of radiotherapy
por: Li, Yong-Heng, et al.
Publicado: (2017)

Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI
por: Bostel, T., et al.
Publicado: (2020)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
por: Spolverato, Gaya, et al.
Publicado: (2011)

ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy
por: Deng, Y, et al.
Publicado: (2014)

Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation
por: Wan, Juefeng, et al.
Publicado: (2015)

An Update on Preoperative Radiotherapy for Locally Advanced Rectal Cancer
por: Yeo, Seung-Gu, et al.
Publicado: (2012)

The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer
por: Oblak, Irena, et al.
Publicado: (2013)

What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
por: Kim, Soo Hee, et al.
Publicado: (2016)

Does total regression of primary rectal cancer after preoperative chemoradiotherapy represent “no tumor” status?
por: Jeong, Seong-A, et al.
Publicado: (2019)

Predictive value of serum alpha-fetoprotein for tumor regression after preoperative chemotherapy for rectal cancer
por: Zhang, Da-Kui, et al.
Publicado: (2022)

Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer
por: Han, Kyung Su, et al.
Publicado: (2016)

Preoperative MRI accuracy after neoadjuvant chemoradiation for locally advanced rectal cancer
por: Popiţa, Anca-Raluca, et al.
Publicado: (2023)

Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
por: Schiffmann, Leif, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sfejaj2mus7f23vgp8l5hq0m47